In addition, research has shown that blood Reelin levels are significantly elevated in patients with liver fibrosis or cirrhosis, and patients with hepatocellular carcinoma (HCC) have markedly higher concentrations of Reelin compared to patients with liver cirrhosis.7 This evidence concerns the gene RELN and hepatocellular carcinoma.